MEDINDIA
English
हिन्दी
Español
français
中文
The new website features an expanded overview of the Company, includingits corporate structure, sales network, R&D efforts, as well as a detailedintroduction to its product portfolio. The new website also includes a richersection dedicated to investor relations, in keeping with its increased profilein the investor community as a U.S. publicly traded company on the NASDAQGlobal Market.
"We are pleased to officially launch our new corporate website, whichserves as a resource for customers, investors, and business partners toefficiently access information on our Company," said Mr. Yan-qing Liu,Chairman and CEO of China Sky One Medical. "Through frequent and regularupdates, we believe our website will become an effective tool to increaseawareness of our business and our products within the investment community."
"We welcome direct communications with our shareholders, and look forwardto answering any questions that they may have," said Mr. Stanley Hao, CFO ofChina Sky One Medical. "Should you have any questions about our business andfinancial statements, please contact us through our outside investor relationsfirm, CCG Investor Relations, or via email at [email protected].
About China Sky One Medical, Inc.
China Sky One Medical, Inc., a Nevada corporation, is a holding company.The Company engages in the manufacturing, marketing and distribution ofpharmaceutical, medicinal and diagnostic products. Through its wholly-ownedsubsidiaries, Harbin Tian Di Ren Medical Science and Technology Company("TDR"), Harbin First Bio-Engineering Company Limited ("First"), HeilongjiangTianlong Pharmaceutical, Inc. ("Tianlong") and Peng Lai Jin ChuangPharmaceutical Company ("Jin Chuang") the Company manufactures and distributesover-the-counter pharmaceutical products, which make up its major revenuesource. For more information, visit http://www.cski.com.cn .
Safe Harbor Statement
Certain of the statements made in the press release constituteforward-looking statements within the meaning of the Private SecuritiesLitigation Reform Act of 1995. These statements can be identified by the useof forward- looking terminology such as "believe," "expect," "may," "will,""should," "project," "plan," "seek," "intend," or "anticipate" or the negativethereof or comparable terminology. Such statements typically involve risksand uncertainties and may include financial projections or informationregarding the launch of new website. Actual results could differ materiallyfrom the expectations reflected in such forward-looking statements as a resultof a variety of factors, including the risks associated with the effect ofchanging economic conditions in The People's Republic of China, variations incash flow, reliance on collaborative retail partners and on new productdevelopment, variations in new product development, risks associated withrapid technological change, and the potential of introduced or undetectedflaws and defects in products, and other risk factors detailed in reportsfiled with the Securities and Exchange Commission from time to time.For more information, please contact: Company Contact: China Sky One Medical, Inc. Mr. Stanley Hao, CFO Tel: +86-451-5399-4069 Email: [email protected] Investor Relations Contact: CCG Investor Relations Mr. Crocker Coulson, President Tel: +1-646-213-1915 Email: [email protected] Web: http://www.ccgirasia.com
SOURCE China Sky One Medical, Inc.
